Lykan BioScience logo — Pioneering advancement in cell-based therapy development and...

Lykan BioScience

Pioneering advancement in cell-based therapy development and manufacturing services

Founded 2019 201-500 employees Private Equity Biotechnology, Manufacturing

General Information

Company Name Lykan BioScience
Founded Year 2019
Employees 201-500
Industries Biotechnology, Manufacturing
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Lykan BioScience. To contact Lykan BioScience, visit lykanbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Lykan BioScience compare?

A PDF of Lykan BioScience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Lykan BioScience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Lykan BioScience

Lykan BioScience is an innovative contract development and manufacturing services organization (CDMO) focusing on cell-based therapies. Pioneering advancement in cell-based therapy development and manufacturing services, the company was founded in 2019 and operates in the Biotechnology and Manufacturing industries. In a Private Equity Round investment at 04 August 2022, the company secured funding from Pleasant Bay Capital Partners, GHO Capital, and WindRose Health Investors. This strategic investment signifies support and confidence from established industry players, positioning Lykan BioScience for further growth and advancements in the field of cell-based therapies.

Business keywords: cell-based therapy, CDMO, manufacturing services, cell therapy, gene therapy, innovation, advanced technology, medical development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 3
Pleasant Bay Capital Partners, GHO Capital +1
04 Aug 2022
Private Equity Round Undisclosed 1
WindRose Health Investors
04 Jun 2019

Lykan BioScience Alternatives & Competitors

View All Alternatives
Lykan BioScience vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
Lykan BioScience vs

Your CDMO Partner from Concept to Commercial for Cell & Gene Therapy Products

Series B
81 employees
Biotechnology, Health Care
Lykan BioScience vs

An integrated cell and gene therapy Contract Testing, Development and Manufacturing Organization (CT...

412 employees
Biotechnology, Life Sciences

FAQ About Lykan BioScience

Pioneering advancement in cell-based therapy development and manufacturing services
Lykan BioScience was founded in 2019.
Lykan BioScience operates in Biotechnology and Manufacturing. Its work centres on cell-based therapy, CDMO, manufacturing services and cell therapy.
Lykan BioScience has approximately 201-500 employees.
Lykan BioScience has completed 2 funding rounds. The latest funding stage is Private Equity.
Top alternatives and competitors to Lykan BioScience include RoslinCT, Cognate BioServices, a Charles River Company, WuXi Advanced Therapies, Porton Advanced | ATMP CDMO/CRO, AGC Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lykan BioScience and RoslinCT are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lykan BioScience, https://bouncewatch.com/company/lykan-bioscience, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes